Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz haqimizda

Biz bilan bog'lanish

[email protected]

Bizni kuzating

Instagram
Telegram
LinkedIn

Barcha huquqlar himoyalangan.

Foydalanish shartlari

Bosh sahifa
Bozorlar
Skriner
Yangiliklar
Biz haqimizda

DOC - Healthpeak Properties, Inc. So'nggi... | Finranks

Home

DOC

H

Healthpeak Properties, Inc. (DOC)

NYQ – Real vaqt narxi. Valyuta: USD

16.59

-0.20 (-1.19%)

Yopilishda: Mar 27, 2026, 4:00 PM EDT

16.61

+0.02 (0.12%)

Bozordan keyin: Mar 27, 2026, 7:56 PM EDT

Umumiy
Yangiliklar
Grafik
Hisobotlar
Dividendlar
Kutilma
Egalik
Profil

REITs: A Regime Change Is Needed

REITs: A Regime Change Is Needed

REITs were rolling out of the gates in early-2026, coming back into favor amid a HALO trade (Heavy Assets, Low Obsolescence) after a half-decade of rate headwinds and unfavorable narrative. The oil price surge tied to the Iran conflict has complicated the rotation by sending rates soaring, yet REITs have remained surprisingly resilient in recent weeks, maintaining sizable year-to-date outperformance. REIT-rate correlations have eased in recent quarters, signaling a more favorable "regime change" where performance is driven by property fundamentals rather than macro forces, following a prolonged period of rate-dominated.

Zealand Pharma Establishes U.S. Research Hub in Cambridge, Massachusetts to Expand Drug Discovery Capabilities and Accelerate Medicine Creation

Zealand Pharma Establishes U.S. Research Hub in Cambridge, Massachusetts to Expand Drug Discovery Capabilities and Accelerate Medicine Creation

Press release – No. 6 / 2026 Zealand Pharma Establishes U.S. Research Hub in Cambridge, Massachusetts to Expand Drug Discovery Capabilities and Accelerate Medicine Creation New research hub in Cambridge, Massachusetts, in the greater Boston area, expands global discovery capabilities, combining Zealand Pharma's more than 25 years of expertise in peptides and metabolic health with Boston's biotech innovation ecosystem.

Healthpeak Properties Closes New $400 Million Delayed-Draw Term Loan Facility

Healthpeak Properties Closes New $400 Million Delayed-Draw Term Loan Facility

DENVER--(BUSINESS WIRE)--Healthpeak Properties, Inc. (NYSE: DOC) (“Healthpeak”), a leading owner, operator, and developer of real estate for healthcare discovery and delivery, announced today that it has closed on a new $400 million unsecured delayed-draw term loan facility (“Term Loan”). “This new term loan enhances our liquidity and financial flexibility and further strengthens our balance sheet,” said Kelvin Moses, Chief Financial Officer of Healthpeak. “We appreciate the continued support o.

Healthpeak Properties and Janus Living Announce Closing of Janus Living Initial Public Offering

Healthpeak Properties and Janus Living Announce Closing of Janus Living Initial Public Offering

DENVER--(BUSINESS WIRE)--Healthpeak Properties, Inc. (NYSE: DOC) (“Healthpeak”) and Janus Living, Inc. (NYSE: JAN) (“Janus Living”) announced today that Janus Living has completed its initial public offering of 48,300,000 shares of its Class A-1 common stock, which includes the exercise in full by the underwriters of their option to purchase up to an additional 6,300,000 shares of Class A-1 common stock, at a price to the public of $20.00 per share. Shares of Janus Living's Class A-1 common sto.

Why Healthpeak Properties Is Of Interest To Me At This Price

Why Healthpeak Properties Is Of Interest To Me At This Price

Healthpeak Properties is rated a "Buy," driven by undervaluation and a 7.16% yield. DOC's strategic shift from SHOP to labs and outpatient medical buildings increases capital intensity and AFFO volatility, but current pricing discounts these risks. I expect limited AFFO growth (0-2%) and earnings compression, positioning DOC as a cash-generating, low-growth REIT.

Should You Buy the 3 Highest-Paying Dividend Stocks in the S&P 500?

Should You Buy the 3 Highest-Paying Dividend Stocks in the S&P 500?

Campbell's boasts many market-leading brands, and it's working to improve its performance. Healthpeak Properties is a real estate investment trust (REIT) with many medical buildings and laboratories.

5 ‘Healthy' Dividends Paying Up To 14.1%

5 ‘Healthy' Dividends Paying Up To 14.1%

Healthcare dividend stocks are selling off with the turbulence in the Middle East.

Videolar

10 Undervalued Dividend Stocks for 2026

Press-relizlar

Zealand Pharma Establishes U.S. Research Hub in Cambridge, Massachusetts to Expand Drug Discovery Capabilities and Accelerate Medicine Creation

Zealand Pharma Establishes U.S. Research Hub in Cambridge, Massachusetts to Expand Drug Discovery Capabilities and Accelerate Medicine Creation

Press release – No. 6 / 2026 Zealand Pharma Establishes U.S. Research Hub in Cambridge, Massachusetts to Expand Drug Discovery Capabilities and Accelerate Medicine Creation New research hub in Cambridge, Massachusetts, in the greater Boston area, expands global discovery capabilities, combining Zealand Pharma's more than 25 years of expertise in peptides and metabolic health with Boston's biotech innovation ecosystem.

Healthpeak Properties Closes New $400 Million Delayed-Draw Term Loan Facility

Healthpeak Properties Closes New $400 Million Delayed-Draw Term Loan Facility

DENVER--(BUSINESS WIRE)--Healthpeak Properties, Inc. (NYSE: DOC) (“Healthpeak”), a leading owner, operator, and developer of real estate for healthcare discovery and delivery, announced today that it has closed on a new $400 million unsecured delayed-draw term loan facility (“Term Loan”). “This new term loan enhances our liquidity and financial flexibility and further strengthens our balance sheet,” said Kelvin Moses, Chief Financial Officer of Healthpeak. “We appreciate the continued support o.

Healthpeak Properties and Janus Living Announce Closing of Janus Living Initial Public Offering

Healthpeak Properties and Janus Living Announce Closing of Janus Living Initial Public Offering

DENVER--(BUSINESS WIRE)--Healthpeak Properties, Inc. (NYSE: DOC) (“Healthpeak”) and Janus Living, Inc. (NYSE: JAN) (“Janus Living”) announced today that Janus Living has completed its initial public offering of 48,300,000 shares of its Class A-1 common stock, which includes the exercise in full by the underwriters of their option to purchase up to an additional 6,300,000 shares of Class A-1 common stock, at a price to the public of $20.00 per share. Shares of Janus Living's Class A-1 common sto.

Healthpeak Properties and Janus Living Announce Pricing of Upsized $840 Million Janus Living Initial Public Offering

Healthpeak Properties and Janus Living Announce Pricing of Upsized $840 Million Janus Living Initial Public Offering

DENVER--(BUSINESS WIRE)--Healthpeak Properties, Inc. (NYSE: DOC) (“Healthpeak”) and Janus Living, Inc. (“Janus Living”) announced the pricing of Janus Living's upsized initial public offering (“IPO”) of 42,000,000 shares of Janus Living Class A-1 common stock at a price to the public of $20.00 per share. In addition, Janus Living has granted the underwriters a 30-day option to purchase up to an additional 6,300,000 shares of its Class A-1 common stock at the initial public offering price, less.